This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38054930
rdf:type
wikibase:Item
schema:description
article científic videnskabelig artikel bilimsel makale vedecký článok wissenschaftlicher Artikel articolo scientifico научная статья বৈজ্ঞানিক নিবন্ধ artikel ilmiah наукова стаття, опублікована в жовтні 2012 vědecký článek научни чланак wetenschappelijk artikel vetenskaplig artikel مقالة علمية نشرت في 23 أكتوبر 2012 scientific article published on 23 October 2012 article scientifique գիտական հոդված հրատարակված 2012 թվականի հոկտեմբերի 23-ին vitenskapelig artikkel מאמר מדעי artigo científico artículo científico artigo científico scienca artikolo artículu científicu espublizáu en 2012 vitskapeleg artikkel artikull shkencor articol științific artigo científico scientific article published on 23 October 2012 scientific article published on 23 October 2012
p:P577
wds:Q38054930-B7EE9099-BC51-4C12-AF54-380350BBD215
wdt:P577
2012-10-23T00:00:00Z
p:P2093
wds:Q38054930-151E9097-1454-40CC-B0E5-E4E675226524
wdt:P2093
Giuseppe Di Lorenzo
rdfs:label
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy. The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.
skos:prefLabel
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy. The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.
schema:name
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy. The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.
p:P50
wds:Q38054930-A2FC0BEC-5702-434F-8E68-51162312765A wds:Q38054930-7A6CE433-8B1C-43DF-9CCA-5E6EE5453BCB wds:Q38054930-8B6A34E0-718C-4E5D-B454-06F8C2FC306B
wdt:P50
wd:Q82941763 wd:Q79313776 wd:Q64495656
p:P1476
wds:Q38054930-3A7B3546-2597-45AF-BE25-EECC38F64303
wdt:P1476
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy
p:P304
wds:Q38054930-42C001D9-EEDD-4000-8538-9432CD0A797C
wdt:P304
42-51
p:P31
wds:Q38054930-AD924789-F4E2-42C3-A386-4CBC4585CF0A
wdt:P31
wd:Q13442814
p:P921
wds:Q38054930-36E0B1CE-1284-445E-AF39-FCA3DDCDA598
wdt:P921
wd:Q181257
p:P698
wds:Q38054930-76887262-1789-43AE-BD61-99970660B8E6
wdtn:P698
n12:23092636
wdt:P698
23092636
p:P1433
wds:Q38054930-9CB0F349-5721-449E-B024-40B6C3AF1607
wdt:P1433
wd:Q15724423
p:P433
wds:Q38054930-0DC3B428-612A-495E-AF99-A8B2E302E16F
p:P478
wds:Q38054930-1392717C-6A4D-4535-852C-AEF5028A3F81
wdt:P433
1
wdt:P478
86
p:P356
wds:Q38054930-B370D6F3-B6F8-4329-B051-58ACED5052DD
wdtn:P356
n10:J.CRITREVONC.2012.09.008
wdt:P356
10.1016/J.CRITREVONC.2012.09.008